Christopher M. Hope

2.2k total citations · 1 hit paper
36 papers, 1.7k citations indexed

About

Christopher M. Hope is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Christopher M. Hope has authored 36 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Immunology and 9 papers in Oncology. Recurrent topics in Christopher M. Hope's work include Immune Cell Function and Interaction (6 papers), Wnt/β-catenin signaling in development and cancer (5 papers) and T-cell and B-cell Immunology (5 papers). Christopher M. Hope is often cited by papers focused on Immune Cell Function and Interaction (6 papers), Wnt/β-catenin signaling in development and cancer (5 papers) and T-cell and B-cell Immunology (5 papers). Christopher M. Hope collaborates with scholars based in Australia, United States and Germany. Christopher M. Hope's co-authors include Randall F. Holcombe, Kestutis Planutis, Anthony V. Nguyen, Robert Carroll, Mary Pat Moyer, Simon C. Barry, Anne R. Simoneau, Bang H. Hoang, Jun Xie and Xiaolin Zi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Christopher M. Hope

36 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection

2022 187 citations Feargal J. Ryan, Christopher M. Hope et al. BMC Medicine profile →

Peers

Christopher M. Hope

ONCOL

IMMUN

SURGE

PRM

Neeraj Jain India

James A. Nathan United Kingdom

Ioulia Chatzistamou United States

Peter Hughes Australia

Wenyan Fu China

Weiwei Liu China

Janice Smith United States

Yoshihiro Yoshida Japan

Graeme Hewitt United Kingdom

Weihua Hu China

Neeraj Jain India

Christopher M. Hope

1.0k ×1.3

464 ×1.3

ONCOL

282 ×1.1

IMMUN

127 ×0.7

SURGE

82 ×0.5

PRM

Citations per year, relative to Christopher M. Hope Christopher M. Hope (= 1×) peers Neeraj Jain

Countries citing papers authored by Christopher M. Hope

Since Specialization

Citations

This map shows the geographic impact of Christopher M. Hope's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher M. Hope with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher M. Hope more than expected).

Fields of papers citing papers by Christopher M. Hope

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher M. Hope. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher M. Hope. The network helps show where Christopher M. Hope may publish in the future.

Co-authorship network of co-authors of Christopher M. Hope

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher M. Hope. A scholar is included among the top collaborators of Christopher M. Hope based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher M. Hope. Christopher M. Hope is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hope, Christopher M., Katherine A. Brown, Cheryl Y. Brown, et al.. (2023). Parallel recovery of chromatin accessibility and gene expression dynamics from frozen human regulatory T cells. Scientific Reports. 13(1). 5506–5506. 5 indexed citations

Ryan, Feargal J., Christopher M. Hope, Makutiro G. Masavuli, et al.. (2022). Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Medicine. 20(1). 26–26. 187 indexed citations breakdown →

Hope, Christopher M., Helena Oakey, Griffith B. Perkins, et al.. (2021). Optimization of Blood Handling and Peripheral Blood Mononuclear Cell Cryopreservation of Low Cell Number Samples. International Journal of Molecular Sciences. 22(17). 9129–9129. 14 indexed citations

Brown, Cheryl Y., Timothy Sadlon, Christopher M. Hope, et al.. (2020). Molecular Insights Into Regulatory T-Cell Adaptation to Self, Environment, and Host Tissues: Plasticity or Loss of Function in Autoimmune Disease. Frontiers in Immunology. 11. 1269–1269. 15 indexed citations

Hope, Christopher M., Griffith B. Perkins, Zhilian Yue, et al.. (2020). Encapsulation of Human Natural and Induced Regulatory T‐Cells in IL‐2 and CCL1 Supplemented Alginate‐GelMA Hydrogel for 3D Bioprinting. Advanced Functional Materials. 30(15). 42 indexed citations

Schjenken, John E., Lachlan M. Moldenhauer, Alison S. Care, et al.. (2020). MicroRNA miR-155 is required for expansion of regulatory T cells to mediate robust pregnancy tolerance in mice. Mucosal Immunology. 13(4). 609–625. 37 indexed citations

Ivask, Angela, Andrew J. Mitchell, Christopher M. Hope, et al.. (2017). Single Cell Level Quantification of Nanoparticle–Cell Interactions Using Mass Cytometry. Analytical Chemistry. 89(16). 8228–8232. 33 indexed citations

Hope, Christopher M., William Hanf, Shilpanjali Jesudason, et al.. (2015). Peripheral natural killer cell and allo-stimulated T-cell function in kidney transplant recipients associate with cancer risk and immunosuppression-related complications. Kidney International. 88(6). 1374–1382. 16 indexed citations

Hope, Christopher M.. (2015). Immune profiling and cancer post transplantation. World Journal of Nephrology. 4(1). 41–41. 7 indexed citations

10.

Hope, Christopher M., et al.. (2014). The immune phenotype may relate to cancer development in kidney transplant recipients. Kidney International. 86(1). 175–183. 37 indexed citations

11.

Ulloa, Jesus G., et al.. (2014). Case Report of Intestinal Tuberculosis 6 Years After Simultaneous Pancreas and Kidney Transplant. Transplantation Proceedings. 46(7). 2450–2452. 6 indexed citations

12.

Seiss, Ellen, et al.. (2014). The Relationship between Reversed Masked Priming and the Tri-Phasic Pattern of the Lateralised Readiness Potential. PLoS ONE. 9(4). e93876–e93876. 6 indexed citations

13.

Hope, Christopher M., Ellen Seiss, P. Dean, Katie Williams, & Annette Sterr. (2013). Consumption of glucose drinks slows sensorimotor processing: double-blind placebo-controlled studies with the Eriksen flanker task. Frontiers in Human Neuroscience. 7. 651–651. 7 indexed citations

14.

Tang, Yaxiong, Anne R. Simoneau, Yi Guo, et al.. (2009). WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells. Molecular Cancer Therapeutics. 8(2). 458–468. 89 indexed citations

15.

Hope, Christopher M., et al.. (2008). Low concentrations of resveratrol inhibit Wnt signal throughput in colon-derived cells: Implications for colon cancer prevention. Molecular Nutrition & Food Research. 52 Suppl 1. S52–61. 108 indexed citations

16.

Zi, Xiaolin, Yi Guo, Anne R. Simoneau, et al.. (2005). Expression of Frzb/Secreted Frizzled-Related Protein 3, a Secreted Wnt Antagonist, in Human Androgen-Independent Prostate Cancer PC-3 Cells Suppresses Tumor Growth and Cellular Invasiveness. Cancer Research. 65(21). 9762–9770. 171 indexed citations

17.

Planutis, Kestutis, et al.. (2005). Effect of resveratrol on Wnt signaling in hematopoietic cells. Cancer Research. 65. 1084–1084. 1 indexed citations

18.

Wagner, Markus, Tracy T. Cao, Martha E. Lopez, et al.. (1996). Expression of a truncated EGF receptor is associated with inhibition of pancreatic cancer cell growth and enhanced sensitivity to cisplatinum. International Journal of Cancer. 68(6). 782–787. 42 indexed citations

19.

Yokoyama, Masaaki, Hitoshi Funatomi, Christopher M. Hope, et al.. (1996). Heparin-binding EGF-like growth factor expression and biological action in human pancreatic cancer cells. International Journal of Oncology. 8(2). 289–95. 3 indexed citations

20.

Kobrin, Michael S., et al.. (1994). A variant epidermal growth factor receptor exhibits altered type alpha transforming growth factor binding and transmembrane signaling.. Proceedings of the National Academy of Sciences. 91(21). 10217–10221. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact